References
- Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol 2003; 38(Suppl 1): S54–68
- The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319(15): 983–9
- de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001; 5(3): 645–63
- Lebrec D, Poynard T, Hillon P, et al. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med 1981; 305(23): 1371–4
- Abraczinskas DR, Ookubo R, Grace ND, et al. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment? Hepatology 2001; 34: 1096–102
- Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 2001; 33(4): 802–7
- Lui HF, Stanley AJ, Forrest EH, et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002; 123(3): 735–44
- Schepke M, Kleber G, Nurnberg D, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2004; 40(1): 65–72
- Levacher S, Letoumelin P, Pateron D, et al. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346(8979): 865–8
- Abraldes JG, Bosch J. Somatostatin and analogues in portal hypertension. Hepatology 2002; 35(6): 1305–12
- Azoulay D, Castaing D, Majno P, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001; 35(5): 590–7
- Henderson JM. Salvage therapies for refractory variceal hemorrhage. Clin Liver Dis 2001; 5(3): 709–25
- Bernard B, Grange JD, Khac EN. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999; 29(6): 1655–61
- Goulis J, Armonis A, Patch D, et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998; 27(5): 1207–12
- Butterworth RF. Hepatic encephalopathy. Alcohol Res Health 2003; 27(3): 240–6
- Lockwood AH. Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis 2004; 19(3–4): 345–9
- Lizardi-Cervera J, Almeda P, Guevara L, et al. Hepatic encephalopathy: a review. Ann Hepatol 2003; 2(3): 122–30
- Williams R, Bass N. Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety. Rev Gastroenterol Disord 2005; 5(Suppl 1): S10–8
- Marchesini G, Marzocchi R, Noia M, et al. Branched-chain amino acid supplementation in patients with liver diseases. J Nutr 2005; 135(Suppl 6): S1596–1601